TYK Medicines gets conditional marketing approval from NMPA
TYK Medicines says its asandeutertinib mesylate tablets (TY-9591) obtained conditional marketing approval from NMPA.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.